articleGastroenterologyJun 2, 2013BRONZE OA

Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis

WJWilliam J. SandbornBGBrian G. FeaganCMColleen MaranoHZHongyan ZhangRSRichard Strauß

University of California San Diego · Western University · +9 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

921
total citations
FWCI
60.73
Percentile
100%
References
27
Citations per year

Authors

15

Topics & keywords

Topics
Keywords
  • Golimumab
  • Ulcerative colitis
  • Medicine
  • Placebo
  • Internal medicine
  • Gastroenterology
  • Clinical endpoint
  • Vedolizumab
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.